NCT07265739 2025-12-11
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
Massachusetts General Hospital
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT05077800 2025-11-18
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT03563248 2025-10-01
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT06135493 2025-04-24
Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
Future University in Egypt
Phase 2 Completed
NCT05637216 2024-09-03
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Shaw Cancer Center
Phase 2 Recruiting
NCT03951142 2023-11-01
ImPRESS
Oslo University Hospital
Phase 2 Unknown
NCT05871333 2023-07-19
Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients
Ain Shams University
Phase 2 Unknown
NCT04447235 2022-08-09
TITAN
Instituto do Cancer do Estado de São Paulo
Phase 2 Terminated
NCT05097248 2021-10-28
Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT01821729 2020-09-25
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Unknown
NCT01234922 2018-08-28
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 2 Terminated